Featured Research

from universities, journals, and other organizations

Common enzyme deficiency may hinder plans to eradicate malaria

Date:
November 13, 2012
Source:
Public Library of Science
Summary:
In malaria-endemic countries, 350 million people are predicted to be deficient in an enzyme that means they can suffer severe complications from taking primaquine, a key drug for treating relapsing malaria, according to a new study.

In malaria-endemic countries, 350 million people are predicted to be deficient in an enzyme that means they can suffer severe complications from taking primaquine, a key drug for treating relapsing malaria, according to a study funded by the Wellcome Trust and published in this week's PLOS Medicine.

Related Articles


This finding is important as primaquine is recommended in the global action plan to eliminate malaria and is the only drug to prevent malaria relapse. The benefits of implementing a treatment program with this drug need to be weighed against the potential harm to a substantial proportion of the population (up to 8%) who may have G6PD deficiency: a genetic defect reducing glucose-6-phosphate dehydrogenase enzyme activitiy. Individuals with G6PD deficiency who are given primaquine can experience a severe complication -- the breakdown of their red blood cells (hemolysis).

The authors from Indonesia, Kenya, the Philippines, and the United Kingdom, led by Rosalind Howes from the University of Oxford, reached these conclusions by inputting information about the frequency of G6PD deficiency from community surveys into a geostatistical model. Using the model, the authors predicted that G6PD deficiency is widespread across malaria-endemic regions, with the lowest frequencies in North and South America and the highest frequency in tropical Africa and the Arabian Peninsula.

Dr Howe explains: "Malaria control and elimination are a top priority on the global health agenda. Yet, a key drug to help achieve this goal remains too dangerous for widespread use. We have developed a map of this risk factor, G6PD deficiency, and find it to be very common across many malaria endemic regions. Much work remains to be done to fully understand this disease, notably its genetic diversity."

The authors found that the predicted frequency of G6PD deficiency varied considerably over relatively short distances in many areas but the overall frequency was 8% in malaria-endemic countries, corresponding to about 350 million affected individuals. In countries that are currently planning to implement malaria elimination programs, the frequency was 5.3%, corresponding to 100 million affected individuals.

When the authors took the severity of the G6PD deficiency (the more severe the deficiency, the higher the risk of hemolysis), they found that the greatest risk was across Asia, where severe G6PD variants are commonly inherited.

The authors say: The prominence of G6PD deficiency represents a barrier to current options for malaria elimination therapy."

They continue: "The complexity and diversity of both malaria epidemiology and G6PD deficiency mean that no single solution will be applicable for ensuring safe and effective primaquine treatment."


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. Rosalind E. Howes, Frιdιric B. Piel, Anand P. Patil, Oscar A. Nyangiri, Peter W. Gething, Mewahyu Dewi, Mariana M. Hogg, Katherine E. Battle, Carmencita D. Padilla, J. Kevin Baird, Simon I. Hay. G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map. PLoS Medicine, 2012; 9 (11): e1001339 DOI: 10.1371/journal.pmed.1001339

Cite This Page:

Public Library of Science. "Common enzyme deficiency may hinder plans to eradicate malaria." ScienceDaily. ScienceDaily, 13 November 2012. <www.sciencedaily.com/releases/2012/11/121113174908.htm>.
Public Library of Science. (2012, November 13). Common enzyme deficiency may hinder plans to eradicate malaria. ScienceDaily. Retrieved March 29, 2015 from www.sciencedaily.com/releases/2012/11/121113174908.htm
Public Library of Science. "Common enzyme deficiency may hinder plans to eradicate malaria." ScienceDaily. www.sciencedaily.com/releases/2012/11/121113174908.htm (accessed March 29, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, March 29, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) — The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) — In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins